A crackdown on unregulated peptides
Show notes
Genomic testing is cheaper than ever and can pick up a risk of disease in people with no family history. Should we expand it nation-wide?
IUDs are a highly effective form of contraception, but some women are concerned about pain. A new study looks at how commonly women experience pain on insertion and why.
Researchers have criticised the current state of peer review for scientific grants in Australia, arguing the process lacks transparency and opportunities for appeal.
And the TGA is cracking down on unregulated peptides, saying they're a safety risk for consumers.
Statement from the Department of Health, Disability and Ageing in response to the Health Report.
For more on peptides, listen to our recent story Who's using peptides, and do we know what's in them?
References
- Diabetes society apologizes after removal of Trump protesters from conference sparks outrage
- Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts
- Egg Allergy Prevalence Before and After Guidelines for Earlier Egg Introduction
- TGA strengthens compliance focus on unapproved peptide products as part of evolving risk response
- TGA cracks down on unregulated peptides, says increased imports are posing a risk to consumer safety
- Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot
- Factors Associated With Pain Related to Insertion of a Contraceptive Intrauterine Device: Findings of a National Survey
- Australia’s erosion of peer review - Science